36C26319R0139-000.docx

FedBizOpps Presolicitation Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE (MM-DD-YYYY)

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field FedBizOpps Presolicitation Notice Rev. March 2010 Q Specialized Laboratory Testing and Consultation Services 55101 36C26319R0139 08-05-2019 N 621511 Department of Veterans Affairs

NETWORK 23 CONTRACTING OFFICE

316 Robert Street N. STE. 506 St. Paul MN 55101 Daniel Vagts daniel.vagts@va.gov Minneapolis VA Medical Center One Veterans Drive 55417 United States va.gov Department of Veterans Affairs daniel.vagts@va.gov Daniel Vagts This is PRE-SOLICITATION NOTICE – The US Department of Veteran Affairs Medical Center, Minneapolis, MN, hereinafter referred to as MVAHCS located at One Veterans Drive, Minneapolis, MN 55417. The NAICS code assigned to this procurement will be 621511 with a size standard of $32.5 million. The VA will award a Single Award, Indefinite Delivery/Indefinite Quantity, commercial services contract. Contract use will be limited to Minneapolis VA Health Care System only. The solicitation will contain requirements for a 12 – month base year with four (4) 12 – month option to renew. Service will begin on September 1, 2019 through August 31, 2020 for the base year. The solicitation is scheduled to be issued on July 15, 2019 and will be issued via FedBizOpps Electronic Posting System at http://www.fedbizopps.gov.

The MVAHCS, requires the services of a contractor to provide highly specialized and specific diagnostic testing needs not provided by the Minneapolis VA Health Care System.

Testing needs may consist of but are not limited to stat and emergent drug levels and beta-2-tranferrin assays; quantitative cryoglobulin levels with identification; HLA typing; coagulation factor assays, consultation on complex anatomic pathology cases, including transplant pathology; and gross and microscopic neuropathology evaluations. See Schedule of items, 3.A., for more extensive list of required testing.

The laboratory must be able to determine levels of the following on a stat or emergent basis:

Amikacin Cyclosporine (by HPLC) Methotrexate Quinidine Sirolimus (by HPLC) Tacrolimus (by HPLC) Tobramycin Beta-2-transferrin Amytriptyline/Nortriptyline Everolimes Procain/NAPA Turn around Times for defined acceptable times of the STAT and emergent testing requirements. Turnaround times are of the utmost importance and the contractor will receive a higher level of evaluation grade for meeting these times. To meet these needs the contractor is required to be no more than 1 hour from pick-up at MVAHCS Laboratory to arrival at the contractor’s laboratory for testing.

Questions regarding this solicitation must be in writing. Questions may be sent via email to: daniel.vagts@va.gov.